Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer

• Paula Paulo,

  Roles Formal analysis, Methodology, Writing – original draft

  Affiliation Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal

  http://orcid.org/0000-0001-8387-2127

  ⨯
• Sofia Maia,

  Roles Investigation, Resources, Writing – review & editing

  Affiliation Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal

  ⨯
• Carla Pinto,

  Roles Validation, Visualization

  Affiliation Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal

  ⨯
• Pedro Pinto,

  Roles Validation, Writing – review & editing

  Affiliation Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal

  ⨯
• Augusta Monteiro,

  Roles Resources, Visualization

  Affiliation Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal

  ⨯
• Ana Peixoto,

  Roles Resources, Validation, Writing – review & editing

  Affiliation Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal

  ⨯
• Manuel R. Teixeira

  Roles Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing

  * E-mail: manuel.teixeira@ipoporto.min-saude.pt

  Affiliations Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal, Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal, Biomedical Sciences Institute Abel Salazar (ICBAS), University of Porto, Porto, Portugal

  http://orcid.org/0000-0002-3633-1659

  ⨯